<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164828">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01935297</url>
  </required_header>
  <id_info>
    <org_study_id>F/14/12</org_study_id>
    <nct_id>NCT01935297</nct_id>
  </id_info>
  <brief_title>Exercise Training After Transcatheter Aortic Valve Implantation</brief_title>
  <acronym>SPORT:TAVI</acronym>
  <official_title>Safety, Applicability and Outcome of Regular Exercise Training After Transcatheter Aortic Valve Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Deutsches Herzzentrum Muenchen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum der Universitaet Muenchen, Grosshadern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study will evaluate the effect of a rehabilitative exercise training on exercise
      capacity in patients after percutaneous aortic valve replacement. It will additionally
      evaluate the safety of such an approach and the effect on life quality. We hypothesize that
      regular structured exercise improves exercise capacity in these patients beyond the sole
      effect of the valve procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will include 30 patients and randomize them in a 1:1-fashion to either a training
      or a usual care group. The training group will undergo 8 weeks of combined endurance and
      resistance training according to a standard protocol, but with individual adjustment if
      required. The usual care group will receive general advice but no structured exercise
      program. Exercise capacity is assessed by cardiopulmonary exercise testing and by the 6
      minute walk test prior to and after the intervention period. In addition, life quality will
      be assessed by validated questionnaires, while safety will be assessed by recording adverse
      events and by echocardiography.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change of peak oxygen uptake</measure>
    <time_frame>Baseline to 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of quality of life</measure>
    <time_frame>Baseline to 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessed by SF-12 and KCCQ questionnaires</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change of valve function</measure>
    <time_frame>Baseline to 8 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Assessed by echocardiography</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Rehabilitation</condition>
  <condition>Exercise</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 weeks of supervised, structured, combined endurance and resistance training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        patients up to 6 months after transcatheter aortic valve implantation

        Exclusion Criteria:

        inability to perform exercise on bicycles valve dysfunction
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Pressler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prevention, Rehabilitation &amp; Sports Medicine, Technische Universität München, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Axel Pressler, MD</last_name>
    <phone>00498928924434</phone>
    <email>pressler@sport.med.tum.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeff Christle</last_name>
    <phone>00498928924421</phone>
    <email>christle@sport.med.tum.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of prevention, rehabilitation and sports medicine</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>80992</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Pressler, MD</last_name>
      <phone>00498928924434</phone>
      <email>pressler@sport.med.tum.de</email>
    </contact>
    <contact_backup>
      <last_name>Jeff Christle, MD</last_name>
      <phone>00498928924421</phone>
      <email>christle@sport.med.tum.de</email>
    </contact_backup>
    <investigator>
      <last_name>Axel Pressler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 5, 2014</lastchanged_date>
  <firstreceived_date>July 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
